Literature DB >> 17943713

Curcumin-derived pyrazoles and isoxazoles: Swiss army knives or blunt tools for Alzheimer's disease?

Rajeshwar Narlawar1, Marcus Pickhardt, Stefanie Leuchtenberger, Karlheinz Baumann, Sabine Krause, Thomas Dyrks, Sascha Weggen, Eckhard Mandelkow, Boris Schmidt.   

Abstract

Curcumin binds to the amyloid beta peptide (Abeta) and inhibits or modulates amyloid precursor protein (APP) metabolism. Therefore, curcumin-derived isoxazoles and pyrazoles were synthesized to minimize the metal chelation properties of curcumin. The decreased rotational freedom and absence of stereoisomers was predicted to enhance affinity toward Abeta(42) aggregates. Accordingly, replacement of the 1,3-dicarbonyl moiety with isosteric heterocycles turned curcumin analogue isoxazoles and pyrazoles into potent ligands of fibrillar Abeta(42) aggregates. Additionally, several compounds are potent inhibitors of tau protein aggregation and depolymerized tau protein aggregates at low micromolar concentrations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17943713     DOI: 10.1002/cmdc.200700218

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  29 in total

1.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

2.  Amyloid β-peptide 25-35 self-assembly and its inhibition: a model undecapeptide system to gain atomistic and secondary structure details of the Alzheimer's disease process and treatment.

Authors:  Marina Naldi; Jessica Fiori; Marco Pistolozzi; Alex F Drake; Carlo Bertucci; Rongliang Wu; Krzysztof Mlynarczyk; Slawomir Filipek; Angela De Simone; Vincenza Andrisano
Journal:  ACS Chem Neurosci       Date:  2012-09-04       Impact factor: 4.418

Review 3.  Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function.

Authors:  David O Kennedy; Emma L Wightman
Journal:  Adv Nutr       Date:  2011-01-10       Impact factor: 8.701

Review 4.  Why pleiotropic interventions are needed for Alzheimer's disease.

Authors:  Sally A Frautschy; Greg M Cole
Journal:  Mol Neurobiol       Date:  2010-05-02       Impact factor: 5.590

5.  5-(1-Cyclo-hexen-1-yl)-3-(4-methoxy-phen-yl)isoxazole.

Authors:  Gabriel Vallejos; Margarita Gutierrez; Luis Astudillo; Iván Brito; Alejandro Cárdenas
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-03-28

6.  Curcumin alters the salt bridge-containing turn region in amyloid β(1-42) aggregates.

Authors:  Venus Singh Mithu; Bidyut Sarkar; Debanjan Bhowmik; Anand Kant Das; Muralidharan Chandrakesan; Sudipta Maiti; Perunthiruthy K Madhu
Journal:  J Biol Chem       Date:  2014-03-05       Impact factor: 5.157

7.  "Clicked" sugar-curcumin conjugate: modulator of amyloid-β and tau peptide aggregation at ultralow concentrations.

Authors:  Sukanta Dolai; Wei Shi; Christopher Corbo; Chong Sun; Saadyah Averick; Dinali Obeysekera; Mina Farid; Alejandra Alonso; Probal Banerjee; Krishnaswami Raja
Journal:  ACS Chem Neurosci       Date:  2011-10-13       Impact factor: 4.418

8.  Synthesis and evaluation of electron-rich curcumin analogues.

Authors:  Michael W Amolins; Laura B Peterson; Brian S J Blagg
Journal:  Bioorg Med Chem       Date:  2008-10-29       Impact factor: 3.641

Review 9.  Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease.

Authors:  P Hemachandra Reddy; Maria Manczak; Xiangling Yin; Mary Catherine Grady; Andrew Mitchell; Sahil Tonk; Chandra Sekhar Kuruva; Jasvinder Singh Bhatti; Ramesh Kandimalla; Murali Vijayan; Subodh Kumar; Rui Wang; Jangampalli Adi Pradeepkiran; Gilbert Ogunmokun; Kavya Thamarai; Kandi Quesada; Annette Boles; Arubala P Reddy
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

10.  The effect of curcumin (turmeric) on Alzheimer's disease: An overview.

Authors:  Shrikant Mishra; Kalpana Palanivelu
Journal:  Ann Indian Acad Neurol       Date:  2008-01       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.